South Korea is intensifying efforts to prevent third-party interference in government support programs for SMEs.
Key measures include improved screening systems, enhanced reporting rewards, and legal reforms.
The latest task force meeting was held on April 10, 2026, with new actions set for rollout in the second half of the year.
South Korea is addressing supply chain disruptions for medical essentials caused by raw material shortages.
The government is prioritizing the supply of key materials and supporting manufacturers and distributors.
As of April 10, 2026, urgent actions and inter-agency coordination are underway.
South Korea is conducting a comprehensive review of its emergency patient transfer and treatment system in Gwangju and Jeolla regions.
The pilot project has shown improvements in transfer efficiency and is being considered for nationwide expansion.
As of April 2024, the government is evaluating results and planning further actions before the pilot concludes.
South Korea has maintained its oil price ceiling for gasoline, diesel, and kerosene in the third round.
The government continues strict monitoring of gas stations and recognizes those contributing to price stability.
The policy is effective from June 10 for two weeks, reflecting recent international market volatility.
South Korea’s biopharmaceutical exports reached a record $2 billion in Q1 2026.
Regulatory reforms and increased global market share fueled the growth.
The sector continues to expand, with Europe leading export destinations.
The South Korean government approved a 26.2 trillion won supplementary budget for 2026.
Key measures include rapid support for households, energy assistance, and industrial supply chain stability.
Implementation began immediately after the April 11 cabinet meeting, with accelerated disbursement planned.